Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-4-7
pubmed:abstractText
The essential contribution of inflammation to tumour development and progression has gained increasing acceptance. For epithelial skin cancer, the observation that tumours arise in sites of chronic irritation and inflammation dates back to 1828 and has stimulated a whole field of research. Chemically-induced mouse skin tumours requiring inflammatory agents such as 12-O-tetradecanoylphorbol 13-acetate (TPA) for tumour-promotion have greatly contributed to our understanding of multi-stage carcinogenesis and have given important insights into the functional interaction between inflammatory micro-environment and epithelial tumour, especially when used in combination with transgenic animals. Data from these and additional new model systems clearly emphasise that the tumour-promoting micro-environment is indispensable for tumour formation and progression. It strongly resembles the wound and is largely orchestrated by inflammatory cells allowing tumour cells to co-opt signalling molecules of the innate immune system to promote their growth, invasion and metastasis. Consequently, anti-inflammatory drugs are of great clinical interest in prevention and treatment of epithelial skin cancers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0959-8049
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
735-44
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Inflammation in epithelial skin tumours: old stories and new ideas.
pubmed:affiliation
Group of Tumor and Microenvironment, German Cancer Research Centre (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. ma.mueller@dkfz-heidelberg.de
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't